⌘K

Home/Filings/4/0001209191-23-044419

4//SEC Filing

Chen Ivan 4

Accession 0001209191-23-044419

CIK 0001006028other

View on SEC.gov Company Profile

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 4:15 PM ET

Size

5.7 KB

Accession

0001209191-23-044419

Insider Transaction Report

Form 4

Period: 2023-08-01

PURE BIOSCIENCE, INC.PURE

Director

Transactions

Award
Stock Option (Right to Buy)
2023-08-01+150,000→ 150,000 total
Exercise: $0.12Exp: 2033-08-01→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2025 or January 15, 2025.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PURE BIOSCIENCE, INC.

CIK 0001006028

Entity typeother

Related Parties

1

filerCIK 0001743729

Filing Metadata

Form type: 4
Filed: Aug 2, 8:00 PM ET
Accepted: Aug 3, 4:15 PM ET
Size: 5.7 KB

View on SEC.gov